Samsung Announces World-First Breakthrough in Fainting Prediction With Galaxy Watch
samsung.com • • technology
Key Points:
- Samsung and Chung-Ang University Gwangmyeong Hospital conducted a joint clinical study validating the Galaxy Watch6's ability to predict vasovagal syncope (VVS) with high accuracy using biosignals.
- VVS, characterized by sudden drops in heart rate and blood pressure causing fainting, affects up to 40% of people, with one-third experiencing recurrent episodes; early prediction can prevent serious injuries from falls.
- The study analyzed heart rate variability data from 132 patients using the Galaxy Watch's PPG sensor and AI algorithms, predicting fainting episodes up to five minutes in advance with 84.6% accuracy, 90% sensitivity, and 64% specificity.
- Published in the European Heart Journal – Digital Health, this research is the first to demonstrate a commercial smartwatch's potential for early syncope prediction, highlighting a shift toward preventive healthcare through wearable technology.
- Samsung plans to enhance its wearable health monitoring features and expand partnerships with medical institutions to lead the digital health industry and promote personalized, preventive health solutions.
